OPKO Health, Inc. (TLV:OPK)
Israel · Delayed Price · Currency is ILS · Price in ILA 389.20
-2.30 (-0.59%)
At close: Jan 30, 2026
OPKO Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 642.07 | 713.14 | 863.5 | 1,004 | 1,775 | 1,435 | |
Revenue Growth (YoY) | -9.75% | -17.41% | -14.01% | -43.42% | 23.64% | 59.15% |
Cost of Revenue | 520.52 | 599.85 | 634.96 | 789.86 | 1,270 | 969.72 |
Gross Profit | 121.55 | 113.3 | 228.53 | 214.33 | 504.67 | 465.69 |
Selling, General & Admin | 234.82 | 304.22 | 300.56 | 372.67 | 468.86 | 355.57 |
Research & Development | 16.66 | - | - | - | - | - |
Amortization of Goodwill & Intangibles | 79.18 | 82.63 | 86.03 | 87.78 | 50.28 | 56.39 |
Operating Expenses | 330.65 | 386.85 | 386.59 | 460.46 | 519.14 | 411.96 |
Operating Income | -209.11 | -273.56 | -158.06 | -246.12 | -14.46 | 53.73 |
Interest Expense | -111.39 | -47.47 | -13.51 | -12.06 | -18.88 | -21.93 |
Interest & Investment Income | 15.29 | 8.43 | 3.98 | 1.98 | 0.03 | 0.15 |
Earnings From Equity Investments | -0.02 | -0.02 | -0.11 | -0.38 | -0.63 | -0.48 |
Currency Exchange Gain (Loss) | -5.4 | -3.8 | 1.2 | -1.8 | -1.4 | 1.6 |
Other Non Operating Income (Expenses) | 163.51 | 164.69 | -18.42 | -149.83 | 3.46 | 11.15 |
EBT Excluding Unusual Items | -147.13 | -151.72 | -184.91 | -408.21 | -31.88 | 44.21 |
Gain (Loss) on Sale of Investments | -109.25 | 19.85 | -0.56 | -3.57 | -4.87 | 0.01 |
Gain (Loss) on Sale of Assets | 101.58 | 121.49 | - | 18.56 | 31.51 | - |
Other Unusual Items | -4.7 | - | 1.04 | 1.31 | -9.41 | 3.99 |
Pretax Income | -159.5 | -10.38 | -184.43 | -391.9 | -14.65 | 48.2 |
Income Tax Expense | 20.89 | 42.84 | 4.44 | -63.5 | 15.49 | 17.62 |
Earnings From Continuing Operations | -180.4 | -53.22 | -188.86 | -328.41 | -30.14 | 30.59 |
Net Income | -180.4 | -53.22 | -188.86 | -328.41 | -30.14 | 30.59 |
Net Income to Common | -180.4 | -53.22 | -188.86 | -328.41 | -30.14 | 30.59 |
Shares Outstanding (Basic) | 729 | 694 | 752 | 719 | 648 | 641 |
Shares Outstanding (Diluted) | 729 | 694 | 752 | 719 | 648 | 641 |
Shares Change (YoY) | 2.26% | -7.68% | 4.55% | 10.95% | 1.16% | 7.59% |
EPS (Basic) | -0.25 | -0.08 | -0.25 | -0.46 | -0.05 | 0.05 |
EPS (Diluted) | -0.25 | -0.08 | -0.25 | -0.46 | -0.05 | 0.05 |
Free Cash Flow | -212.06 | -208.5 | -44.47 | -119.77 | 6.18 | 5.79 |
Free Cash Flow Per Share | -0.29 | -0.30 | -0.06 | -0.17 | 0.01 | 0.01 |
Gross Margin | 18.93% | 15.89% | 26.47% | 21.34% | 28.44% | 32.44% |
Operating Margin | -32.57% | -38.36% | -18.30% | -24.51% | -0.81% | 3.74% |
Profit Margin | -28.10% | -7.46% | -21.87% | -32.70% | -1.70% | 2.13% |
Free Cash Flow Margin | -33.03% | -29.24% | -5.15% | -11.93% | 0.35% | 0.40% |
EBITDA | -115.81 | -175.38 | -52.76 | -137.47 | 64.26 | 139.09 |
EBITDA Margin | -18.04% | -24.59% | -6.11% | -13.69% | 3.62% | 9.69% |
D&A For EBITDA | 93.29 | 98.18 | 105.3 | 108.66 | 78.72 | 85.36 |
EBIT | -209.11 | -273.56 | -158.06 | -246.12 | -14.46 | 53.73 |
EBIT Margin | -32.57% | -38.36% | -18.30% | -24.51% | -0.81% | 3.74% |
Effective Tax Rate | - | - | - | - | - | 36.55% |
Revenue as Reported | 642.07 | 713.14 | 863.5 | 1,004 | 1,775 | 1,435 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.